Group One Trading’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $325K | Buy |
+60,041
| New | +$230K | ﹤0.01% | 3884 |
|
|
2026
Q1 | – | Sell |
-3,591
| Closed | -$11.4K | – | 7935 |
|
|
2025
Q4 | $14.4K | Buy |
3,591
+3,197
| +811% | +$17.8K | ﹤0.01% | 6594 |
|
|
2025
Q3 | $3.33K | Sell |
394
-3,299
| -89% | -$32K | ﹤0.01% | 7733 |
|
|
2025
Q2 | $41.6K | Buy |
+3,693
| New | +$33.9K | ﹤0.01% | 5731 |
|
|
2025
Q1 | – | Sell |
-25,806
| Closed | -$261K | – | 7804 |
|
|
2024
Q4 | $290K | Buy |
+25,806
| New | +$454K | ﹤0.01% | 3612 |
|
|
2024
Q3 | – | Sell |
-21,066
| Closed | -$543K | – | 6811 |
|
|
2024
Q2 | $403K | Buy |
+21,066
| New | +$538K | ﹤0.01% | 2758 |
|
|
2024
Q1 | – | Sell |
-115,044
| Closed | -$3.67M | – | 7281 |
|
|
2023
Q4 | $3.8M | Buy |
115,044
+113,923
| +10,163% | +$3.22M | 0.01% | 1341 |
|
|
2023
Q3 | $30.5K | Hold |
1,121
| – | – | ﹤0.01% | 5531 |
|
|
2023
Q2 | $34K | Buy |
+1,121
| New | +$36.2K | ﹤0.01% | 5582 |
|
|
2023
Q1 | – | Sell |
-1,822
| Closed | -$57.6K | – | 7398 |
|
|
2022
Q4 | $51.2K | Buy |
1,822
+1,628
| +839% | +$46.7K | ﹤0.01% | 4975 |
|
|
2022
Q3 | $7K | Sell |
194
-34,190
| -99% | -$1.2M | ﹤0.01% | 6693 |
|
|
2022
Q2 | $1.06M | Buy |
34,384
+29,465
| +599% | +$859K | ﹤0.01% | 2706 |
|
|
2022
Q1 | $159K | Buy |
+4,919
| New | +$129K | ﹤0.01% | 5042 |
|
|
2021
Q1 | – | Sell |
-76,759
| Closed | -$1.46M | – | 7685 |
|
|
2020
Q4 | $1.23M | Buy |
+76,759
| New | +$1.01M | ﹤0.01% | 2473 |
|
|
2020
Q3 | – | Sell |
-1,594
| Closed | -$18.7K | – | 6208 |
|
|
2020
Q2 | $11K | Sell |
1,594
-12,684
| -89% | -$84.9K | ﹤0.01% | 5074 |
|
|
2020
Q1 | $78K | Sell |
14,278
-100,376
| -88% | -$897K | ﹤0.01% | 3460 |
|
|
2019
Q4 | $1.04M | Buy |
114,654
+29,869
| +35% | +$243K | 0.01% | 1839 |
|
|
2019
Q3 | $610K | Buy |
84,785
+76,747
| +955% | +$551K | ﹤0.01% | 2158 |
|
|
2019
Q2 | $64K | Buy |
+8,038
| New | +$95.2K | ﹤0.01% | 3634 |
|
|
2019
Q1 | – | Sell |
-3,089
| Closed | -$62K | – | 4959 |
|
|
2018
Q4 | $62K | Sell |
3,089
-8,992
| -74% | -$208K | ﹤0.01% | 3435 |
|
|
2018
Q3 | $343K | Buy |
12,081
+6,574
| +119% | +$157K | ﹤0.01% | 2602 |
|
|
2018
Q2 | $116K | Buy |
+5,507
| New | +$104K | ﹤0.01% | 3451 |
|
|
2018
Q1 | – | Sell |
-14,785
| Closed | -$212K | – | 4954 |
|
|
2017
Q4 | $182K | Sell |
14,785
-40,988
| -73% | -$578K | ﹤0.01% | 2977 |
|
|
2017
Q3 | $993K | Buy |
+55,773
| New | +$1.15M | 0.01% | 1570 |
|
|
2017
Q1 | – | Sell |
-356
| Closed | -$6.83K | – | 4723 |
|
|
2016
Q4 | $5K | Sell |
356
-2,400
| -87% | -$47.3K | ﹤0.01% | 4094 |
|
|
2016
Q3 | $68K | Buy |
+2,756
| New | +$64.4K | ﹤0.01% | 3159 |
|
|
2016
Q2 | – | Sell |
-800
| Closed | -$11K | – | 4695 |
|
|
2016
Q1 | $8K | Sell |
800
-1,200
| -60% | -$12.4K | ﹤0.01% | 4083 |
|
|
2015
Q4 | $24K | Buy |
+2,000
| New | +$29.5K | ﹤0.01% | 3819 |
|
Other funds holding EVH
CCM
RF
EC
Group One Trading's EVH Position: Q2 2026 in Review
Group One Trading opened a new position in Evolent Health (EVH) in Q2 2026: 60,041 shares worth $325K. The stake represents ﹤0.01% of the portfolio and ranks #3884 among its holdings. This is a return to the name: Group One Trading previously reported a position in EVH as recently as Q4 2025.
Group One Trading first reported a position in EVH in Q4 2015 and has held it in 28 quarters since. The position peaked at $3.8M in Q4 2023. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.
- Group One Trading held 60,041 shares of Evolent Health worth $325K as of Q2 2026.
- Evolent Health was a new Group One Trading position in Q2 2026.
- Evolent Health made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3884 holding.
- Group One Trading first reported a position in Evolent Health in Q4 2015 and has held it in 28 quarters since.
- Group One Trading's Evolent Health position peaked at $3.8M in Q4 2023.
- 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.